#ITI#Pathogenesis of and immunity to a new influenza A (H5N1) virus isolated from duck meat#FTI#
#IRE#The outbreak of avian influenza H5N1 in Hong Kong in 1997 raised concerns about the potential for the H5 subtype to cause a human pandemic. In 2001 a new H5N1 virus, A/Duck Meat/Anyang/AVL-1/2001 (A/Dkmt), was isolated from imported duck meat in Korea. The pathogenesis of this virus was investigated in mice. A/Dkmt virus had low infectivity but was lethal for mice at high doses, and at lethal doses, the virus replicated in the brains of infected mice. A/Dkmt virus cross-reacted poorly with ferret antisera raised against human H5N1 viruses, but prior infection with A/Dkmt virus protected mice from death after secondary infection with human H5N1 virus.#FRE#
#IPC#Antigenicity; Avian influenza virus; Cross-protection; Pathogenesis#FPC#
#IRF#Alexander D.J., A review of avian influenza in different bird species, Vet. Microbiol., 74, pp. 3-13, (2000); 
Bender C., Hall H., Huang J., Klimov A., Cox N., Hay A., Gregory V., Cameron K., Lim W., Subbarao K., Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998, Virology, 254, pp. 115-123, (1999); 
Cauthen A.N., Swayne D.E., Schultz-Cherry S., Perdue M.L., Suarez D.L., Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans, J. Virol., 74, pp. 6592-6599, (2000); 
Claas E.C.J., Osterhaus A.D.M.E., Van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., Krauss S., Shortridge K.F., Webster R.G., Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus, Lancet, 351, pp. 472-477, (1998); 
Cyranoski D., Outbreak of chicken flu rattles Hong Kong, Nature, 412, (2001); 
De Jong J.C., Claas E.C.J., Osterhaus A.D.M.E., Webster R.G., Lim W.L., A pandemic warning?, Nature, 389, (1997); 
Gao P., Watanabe S., Ito T., Goto H., Wells K., McGregor M., Cooley A.J., Kawaoka Y., Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong, J. Virol., 73, pp. 3184-3189, (1999); 
Gorman O.T., Bean W.J., Kawaoka Y., Donatelli I., Guo Y., Webster R.G., Evolution of influenza A virus nucleoprotein genes: Implications for the origins of H1N1 human and classical swine viruses, J. Virol., 65, pp. 3704-3714, (1991); 
Hiromoto Y., Yamazaki Y., Fukushima T., Saito T., Lindstrom S.E., Omoe K., Nerome R., Lim W., Sugita S., Nerome K., Evolutionary characterization of the six internal genes of H5N1 human influenza A virus, J. Gen. Virol., 81, pp. 1293-1303, (2000); 
Katz J.M., Lim W., Bridges C.B., Rowe T., Hu-Primmer J., Lu X., Abernathy R.A., Clarke M., Conn L., Kwong H., Lee M., Au G., Ho Y.Y., Mak K.H., Cox N.J., Fukuda K., Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts, J. Infect. Dis., 180, pp. 1763-1770, (1999); 
Katz J.M., Lu X., Tumpey T.M., Smith C.B., Shaw M.W., Subbarao K., Molecular correlates of influenza A H5N1 virus pathogenesis in mice, J. Virol., 74, pp. 108070-108810, (2000); 
Kawaoka Y., Krauss S., Webster R.G., Avian-to-human transmission of the PB1 of influenza A viruses in the 1957 and 1968 pandemics, J. Virol., 63, pp. 4603-4608, (1989); 
Kendal A.P., Skehel J.J., Pereira M.S., Concepts and Procedures for Laboratory-Based Influenza Surveillance, (1982); 
Lu X., Tumpey T.M., Morken T., Zaki S.R., Cox N.J., Katz J.M., A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans, J. Virol., 73, pp. 5903-5911, (1999); 
Nicholson K.G., Colegate A.E., Podda A., Stephenson I., Wood J., Ypma E., Zambon M.C., Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: A randomized trial of two potential vaccines against H5N1 influenza, Lancet, 357, pp. 1937-1943, (2001); 
Nishimura H., Itamura S., Iwasaki T., Kurata T., Tashiro M., Characterization of human influenza A (H5N1) virus infection in mice: Neuro-, pneumo- and adipotropic infection, J. Gen. Virol., 81, pp. 2503-2510, (2000); 
Reed L.J., Muench H., A simple method for estimating fifty percent endpoints, Am. J. Hyg., 27, pp. 493-497, (1938); 
Rohm C., Zhou N., Suss J., MacKenzie J., Webster R.G., Characterization of a novel influenza hemagglutinin, H15: Criteria for determination of influenza A subtypes, Virology, 217, pp. 508-516, (1996); 
Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X.H., Lim W., Fukuda K., Cox N.J., Katz J.M., Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays, J. Clin. Microbiol., 37, pp. 937-943, (1999); 
Scholtissek C., Rohde W., Von Hoyningen V., Rott R., On the origin of the human influenza virus subtypes H2N2 and H3N2, Virology, 87, pp. 13-20, (1978); 
Shortridge K.F., Zhou N.N., Guan Y., Gao P., Ito T., Kawaoka Y., Kodihalli S., Krauss S., Markwell D., Murti K.G., Norwood M., Senne D., Sims L., Takada A., Webster R.G., Characterization of avian H5N1 influenza viruses from poultry in Hong Kong, Virology, 252, pp. 331-342, (1998); 
Suarez D.L., Perdue M.L., Cox N.J., Rowe T., Bender C., Huang J., Swayne D.E., Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong, J. Virol., 72, pp. 6678-6688, (1998); 
Subbarao K., Klimov A., Katz J.M., Regnery H., Lim W., Hall H., Perdue M., Swayne D., Bender C., Huang J., Hemphill M., Rowe T., Shaw M., Xu X., Fukuda K., Cox N., Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness, Science, 279, pp. 393-396, (1998); 
Taubenberger J.K., Reid A.H., Krafft A.E., Bijwaard K.E., Fanning T.G., Initial genetic characterization of the 1918 "Spanish" influenza virus, Science, 275, pp. 1793-1796, (1997); 
Tumpey T.M., Lu X., Morken T., Zaki S.R., Katz J.M., Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans, J. Virol., 74, pp. 6105-6116, (2000); 
Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y., Evolution and ecology of influenza A viruses, Microbiol. Rev., 56, pp. 152-179, (1992); 
Webster R.G., Guan Y., Peiris M., Walker D., Krauss S., Zhou N.N., Govorkova E.A., Ellis T.M., Dyrting K.C., Sit T., Perez D.R., Shortridge K.F., Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China, J. Virol., 76, pp. 118-126, (2002); 
Wood J.M., Major D., Daly J., Newman R.W., Dunleavy U., Nicolson C., Robertson J.S., Schild G.C., Lee-Lin Y.N., Vaccines against H5N1 influenza, Vaccine, 18, pp. 579-580, (2000); 
Yuen K.Y., Chan P.K., Peiris M., Tsang D.N.C., Que T.L., Shortridge K.F., Cheung P.T., To W.K., Ho E.T.F., Sung R., Cheng A.F.B., Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus, Lancet, 351, pp. 467-471, (1998)#FRF#
